National Kidney Foundation Names Marc Hurlbert CEO Amid Public Health Crisis
Event summary
- Dr. Marc Hurlbert began his tenure as CEO of the National Kidney Foundation on July 1, 2026.
- Hurlbert brings 25 years of experience in healthcare leadership and has overseen $750 million in funding for public health initiatives.
- He prioritizes listening to stakeholders to shape NKF's future strategies, focusing on education, transplantation, and early intervention.
- Kevin Longino, former CEO since 2015, will support the transition.
The big picture
Hurlbert’s appointment comes as chronic kidney disease (CKD) remains an under-recognized public health burden, affecting 1 in 7 U.S. adults. His background in funding allocation and cross-sector collaboration positions NKF to address disparities in kidney care, particularly among high-risk populations. The transition also highlights the growing urgency for earlier detection and intervention in a rapidly advancing scientific landscape.
What we're watching
- Strategic Priorities
- How Hurlbert's focus on education and early intervention will reshape NKF's advocacy efforts.
- Stakeholder Engagement
- Whether the new CEO can effectively integrate feedback from diverse stakeholders to drive impact.
- Innovation Leadership
- The pace at which NKF advances research and collaboration across sectors under Hurlbert's leadership.
Related topics